Brand-quality audit Published Sep 28, 2025 Recalibrated Jun 14, 2026

Kirkman (Kirkman® / Kirkman Laboratories / Kirkman Group)

Specialty hypoallergenic supplement brand with strong testing claims but a serious recent FDA drug-manufacturing regulatory cloud.

Composite trust

57 /100 Poor

Quality

43 /100

Poor

Formulation

77 /100

Adequate

Transparency

55 /100

Poor

Safety

33 /100

Poor

Value

54 /100

Poor

Sentiment

80 /100

Strong

Top strengths

Broad disclosed Ultra Tested® program with named methods and contaminant categories
Strong specialty formulation fit for hypoallergenic/sensitive users
Clear ownership and facility-location disclosure through SEC and brand sources
Generally positive niche sentiment and BBB A+ rating

Key concerns

Recent January 2026 FDA drug CGMP warning letter at HTO Nevada Inc. dba Kirkman
2026 voluntary Class II OTC drug recall tied to stability data not supporting expiry dates
No public batch COA portal or lot-level test-result lookup found
Current NSF/USP certification not verified in official NSF GMP listing checked

Badges

Third-party tested Effective dosing Premium ingredients Transparent pricing Community favorite Recent safety issue

Axis by axis

What the evidence shows

Quality

43/100 Poor

Kirkman's quality story is split. The brand discloses a broad, method-specific Ultra Tested® program and in-house manufacturing, which are stronger than many supplement brands. But the January 2026 FDA warning letter and related 2026 Class II drug recall materially undermine confidence in the same facility's quality systems, especially around quality-unit oversight, process validation, contract testing oversight, and stability support.

Formulation

77/100 Adequate

Sampled Kirkman formulas are generally better than generic mass-market formulas on ingredient form, allergen avoidance, and transparent active dosing. The formulation evidence is strongest for minerals, methylated B vitamins, vitamin D, and probiotics. The main limitations are lack of Kirkman-owned clinical trials and some broad structure/function claims that go beyond product-specific evidence.

Transparency

55/100 Poor

Kirkman is more transparent than average on ownership, facility location, and testing categories. The major transparency gap is verification: no public COA portal, no lot-level batch lookup, no named lab list, and no current NSF listing found despite older NSF references. The 2026 FDA warning letter further weakens trust in unverified testing claims because it specifically criticized contract testing oversight and stability systems for drug products.

Safety

33/100 Poor

Kirkman's safety score is pulled down by recent, official FDA evidence. The key issue is not a proven contaminated supplement; it is a recent FDA drug CGMP warning letter at the same Kirkman facility, repeat observations, and a 2026 Class II OTC drug recall tied to unsupported expiry dating. Because these events are within the last two years, the rubric applies full recency weight.

Value

54/100 Poor

Kirkman is a premium specialty brand, not a bargain brand. The price premium is partly justified by hypoallergenic positioning, specialty nutrient forms, and testing claims, but it is harder to justify without public COAs and current NSF/USP verification. Generic categories such as vitamin D show a large premium versus budget competitors, while specialty forms such as magnesium bisglycinate and zinc picolinate look more reasonable.

Sentiment

80/100 Strong

Kirkman has a generally positive niche reputation, especially among sensitive users and practitioner-adjacent communities, and BBB lists an A+ rating. Product reviews on Kirkman's site are mostly favorable, but they are seller-hosted and may predate the 2026 FDA action. Social sentiment is therefore stronger than the current regulatory record would suggest.

The rubric

How every score was built

Each axis opens at a category baseline, then moves only on dated, cited evidence, never a gut call. That is the whole difference from a star rating: every one of these 41 adjustments is a receipt you can check.

Points	What moved the score
Quality baseline 50 43 Poor
+10	Third-party independent testing disclosed: Kirkman states its Ultra Tested® program uses independent ISO/IEC 17025 laboratories, raw-material identity testing, heavy-metal testing, microbiology testing, and finished-product testing. Awarded high within +8 to +12 range because the testing scope is broad, but not the full amount because lab names and batch COAs are not publicly posted. Calculation: +10 × full recency weight = +10. ²³ Current website evidence observed in 2026; positive operational claim, no temporal discount applied. · full weight
+8	ISO 17025 testing framework disclosed: Kirkman claims all labs used for Ultra Tested® assays must be ISO 17025 certified. Awarded +8 of +8 to +12 because the standard is named, but the specific lab certificates/scopes were not publicly verifiable from Kirkman's site. Calculation: +8 × full = +8. ³ Current website evidence observed in 2026; no temporal discount applied. · full weight
+5	Heavy-metal testing disclosed: Kirkman states raw materials and finished products are analyzed for heavy metals using ICP-MS and that California Prop 65 procedures are followed where applicable. Awarded +5 of +3 to +6 because the method and raw/finished-product stages are described, but batch results are not public. Calculation: +5 × full = +5. ²³ Current website evidence observed in 2026; no temporal discount applied. · full weight
+5	Microbiological testing disclosed: Kirkman states it monitors raw materials and finished products for yeast, mold, aerobic plate counts, and pathogens including E. coli, Salmonella, Staphylococcus aureus, and Listeria. Awarded +5 of +3 to +6 because the organism panel is specific, but results are not public. Calculation: +5 × full = +5. ³ Current website evidence observed in 2026; no temporal discount applied. · full weight
+5	Ingredient identity testing disclosed: Kirkman states raw-material identity is verified through third-party labs using HPTLC, HPLC, FTIR, ICP-MS, and ICP-OES. Awarded +5 of +3 to +6 for named identity methods and third-party involvement. Calculation: +5 × full = +5. ³ Current website evidence observed in 2026; no temporal discount applied. · full weight
+4	Own manufacturing facility and internal QA controls: Kirkman states it manufactures nearly all products in its own Lake Oswego facility, double-checks raw-material weighing and blending, and uses an independent quality-control department during production and packaging. Awarded +4 of +3 to +6 because the controls are described, but not independently audited in the source. Calculation: +4 × full = +4. ¹⁴ Current website evidence observed in 2026; no temporal discount applied. · full weight
−28	Recent FDA warning letter for drug CGMP violations at the same Lake Oswego facility: FDA inspected HTO Nevada, Inc. dba Kirkman on August 18-22, 2025 and issued a January 27, 2026 warning letter citing significant finished-pharmaceutical CGMP violations, inadequate quality-unit oversight, inadequate process validation, incomplete stability program, and inadequate CAPA. This is not a dietary-supplement Part 111 warning letter, so I used the lower-middle of the -25 to -35 range rather than the maximum. Calculation: -28 × full recency weight = -28. ⁵ January 27, 2026; within last 2 years, 100% weight. · full weight
−6	Repeat FDA observations: the 2026 FDA letter states a previous March 19, 2019 inspection cited similar CGMP observations and that repeated failures demonstrated inadequate executive management oversight for drug manufacturing. Scored as FDA 483/inspection-observation history at the low end of -10 to -15, then 50% temporal discount because 2019 is 5-10 years before the scoring date. Calculation: -12 × 50% = -6. ⁵ March 19, 2019 prior inspection; 5-10 years old, 50% weight. · 50% weight
−10	Class II drug recall tied to stability-data support: FDA-derived recall records report a February 18, 2026 voluntary nationwide Class II recall by HTO Nevada Inc. dba Kirkman for lidocaine/racepinephrine and lidocaine/epinephrine products because stability data did not support expiry dates. Scored as a quality-system/stability failure at -10 because it is recent and multi-event, but self-initiated and tied to OTC drugs rather than Kirkman dietary supplements. Calculation: -10 × full = -10. ⁹¹⁰ February-March 2026; within last 2 years, 100% weight. · full weight
—	Not scored No public batch COA portal, no current NSF/USP certificate for Kirkman found in current NSF listings, no lab names/scopes for the ISO 17025 laboratories used in Ultra Tested®, and no public FDA closeout letter for the January 2026 warning letter located during this review.
Formulation baseline 50 77 Adequate
+10	Effective dosing pattern in sampled core nutrient products: Of 10 sampled Kirkman product pages, 8 had clear, conventional nutrient doses or CFU levels for their category: Vitamin D3 4000 IU, zinc picolinate 25 mg, magnesium bisglycinate 100 mg, 5-MTHF 400 mcg or 5 mg, calcium 200 mg with D3, methylcobalamin, TMG 500 mg, and 60B CFU probiotic. Applying lower end of +10 to +15 because this is a sample and many products target maintenance or practitioner-guided use rather than clinical trial endpoints. Calculation: +10 × full = +10. ¹⁸¹⁹²⁰²¹²³²⁴²⁵²⁶²⁷²⁸²⁹³⁸ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+7	Premium or bioavailable ingredient forms in sampled products: Sampled pages show zinc picolinate, magnesium bisglycinate, calcium bisglycinate, L/6S-5-MTHF, methylcobalamin, and a branded probiotic ingredient LactoSpore® in Mushroom Gut Health. This is a significant pattern across sampled products, not a comprehensive full-line audit. Awarded +7 of +5 to +8. Calculation: +7 × full = +7. ¹⁸²⁰²¹²³²⁵²⁴ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+6	Bioavailability technology/forms: Kirkman uses a Bio-Max positioning for magnesium bisglycinate and describes chelated/mineral forms intended for absorption or gentleness. Awarded +6 of +8 to +12 because the forms are credible, but the evidence is ingredient-form based rather than Kirkman-owned bioavailability trials. Calculation: +6 × full = +6. ²¹²⁵ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+5	No widespread proprietary-blend concealment in sampled products: Most sampled single-nutrient and multi-nutrient products list named actives and amounts; however, some products use proprietary or blend-style formulations, including Enzyme-Aid™ and mushroom blends. Pattern calculation: 8 of 10 sampled products had clear active dosing, 80% of sample, so +5 of +5 to +7. Calculation: +5 × full = +5. ¹⁸¹⁹²⁰²¹²²²³²⁴²⁵³⁸³⁹ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+4	Minimal-fillers/clean-label tendency in sampled hypoallergenic single-nutrient products: Several sampled products use short inactive-ingredient lists and emphasize free-of-major-allergen positioning. Awarded +4 of +3 to +5 because this is strong in hypoallergenic products but not universal; B12 powder and some chewables use sweeteners/flavors, and multi-ingredient products naturally contain more excipients. Calculation: +4 × full = +4. ¹⁸¹⁹²⁰²¹²³²⁵ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+4	Synergistic combinations: Sampled products include calcium with vitamin D3 and methylation-support formulas combining TMG, folate, and methyl B12. Awarded +4 of +5 to +8 because combinations are rational but not supported by Kirkman-owned clinical trials in the sources found. Calculation: +4 × full = +4. ²⁵³⁸ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
−5	Claims without strong product-specific evidence: Some product pages make broad structure/function statements, including TMG language about athletic performance, insulin levels, and depression support, while no Kirkman-owned clinical trials were found. This appears limited rather than systematic, so scored below midpoint. Calculation: -5 of -8 to -12 × full = -5. ³⁸ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
−4	Cheap/less-preferred forms in sampled multivitamin: Kirkman's Advanced Adult Multivitamin includes magnesium from magnesium oxide and vitamin B12 as cyanocobalamin, although it also includes premium forms such as 5-MTHF and chelated minerals. This was one sampled product and below a broad pattern threshold, but the multivitamin is central enough to score a small penalty above the 2-point minimum. Calculation: -4 of -8 to -12 × partial pattern = -4. ²² Current product-page evidence observed in 2026; no temporal discount applied. · full weight
—	Not scored This was a sampled-product review, not a full 400-product label audit. Several product pages did not expose complete Supplement Facts amounts in searchable text, and no Kirkman-owned clinical trial database or published product-specific trial list was found.
Transparency baseline 50 55 Poor
+10	Ownership structure substantially disclosed through SEC filings: Functional Brands Inc. disclosures state that HTO Nevada Inc. dba Kirkman is a wholly owned subsidiary of Functional Brands, that Functional Brands is majority-owned by Hemptown Organics Corp., and that Kirkman assets were acquired in 2019 with restructuring in 2023. Awarded +10 of +8 to +12 because SEC filings provide unusually detailed ownership and transaction history. Calculation: +10 × full = +10. ¹⁴¹⁵ SEC and investor disclosures available in 2024-2026; no negative temporal discount for transparency disclosure. · full weight
+7	Manufacturing location disclosed: Kirkman publishes its Lake Oswego, Oregon shop/manufacturing address and states products are manufactured in Lake Oswego. Awarded +7 of +6 to +10 because the facility address is clear, but the site does not provide a current third-party facility certificate. Calculation: +7 × full = +7. ¹⁴ Current website evidence observed in 2026; no temporal discount applied. · full weight
+8	Third-party testing program disclosed: Kirkman discloses the Ultra Tested® program, testing categories, and several methods. Awarded +8 of +8 to +12 for meaningful disclosure, not higher because there is no public COA portal and no named lab list. Calculation: +8 × full = +8. ²³ Current website evidence observed in 2026; no temporal discount applied. · full weight
+4	Clear active-ingredient labeling in sampled products: Sampled products generally list active nutrient forms and amounts, especially single-nutrient products. Awarded +4 of +3 to +5 because sampled labels are generally clear, though not all products are simple formulas. Calculation: +4 × full = +4. ¹⁸¹⁹²⁰²¹²²²³²⁴²⁵ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
−8	No public COA portal or batch lookup found despite heavy testing claims: Absence of public COAs is not penalized by itself under the rubric, but Kirkman makes premium testing claims and does not let shoppers verify batch-level results online. Scored as claims partially unverifiable, not as COA refusal. Calculation: -8 of -10 to -15 × full = -8. ²³ Current 2026 transparency gap; full weight. · full weight
−6	No detailed ingredient sourcing supply chain: Kirkman says it uses certified suppliers and monitors raw materials, but does not publish supplier names, country-of-origin details, or full supply-chain traceability. Premium/specialty positioning justifies a modest penalty. Calculation: -6 of -6 to -10 × full = -6. ¹ Current 2026 transparency gap; full weight. · full weight
−4	Current NSF status not verified in official listing: historical sources mention NSF/cGMP certification, but the current NSF GMP listing page checked for this review did not contain 'Kirkman.' Because Kirkman's current site does not prominently claim current NSF certification, scored as a small verification concern rather than an unverifiable-certification penalty. Calculation: -4 of -8 to -12 × partial/mitigated = -4. ¹¹¹²¹³ Current NSF listing checked in June 2026; full weight for present verification status. · full weight
−6	FDA warning letter conflicts with testing/quality transparency claims for drug operations: FDA specifically cited inadequate oversight for contract testing laboratories and inadequate stability/testing systems for drug products. This does not prove supplement COAs are wrong, but it weakens confidence in unverified testing claims. Calculation: -6 of -10 to -15 × mitigated because drug-specific = -6. ⁵ January 27, 2026; within last 2 years, 100% weight. · full weight
—	Not scored No public batch COAs, no published lot lookup, no named third-party lab list, no current NSF/USP certificate found, and no public FDA closeout letter for the 2026 warning letter.
Safety baseline 90 33 Poor
−30	Recent FDA warning letter for significant finished-pharmaceutical CGMP violations: FDA's January 27, 2026 letter states Kirkman's drug products were adulterated because methods/facilities/controls did not conform to CGMP, and cited inadequate quality-unit oversight, process validation, and stability program. Scored high in -25 to -35 because it is recent and systemic, but not maximum because it concerns OTC drug manufacturing rather than the dietary-supplement line. Calculation: -30 × full recency weight = -30. ⁵ January 27, 2026; within last 2 years, 100% weight. · full weight
−15	Voluntary Class II recall in 2026: FDA-derived recall records report a voluntary, ongoing, nationwide Class II recall initiated February 18, 2026 for three OTC drug product events because stability data did not support expiry dates. Scored as serious voluntary recall at midpoint of -12 to -18 because Class II recalls can cause temporary or medically reversible adverse health consequences or remote probability of serious harm, but this was self-initiated and not a Class I recall. Calculation: -15 × full = -15. ⁹¹⁰ February-March 2026; within last 2 years, 100% weight. · full weight
−6	Historical FDA warning letter for unapproved fluoride drugs: FDA's unapproved-drug action list identifies Kirkman Laboratories, Inc. with a January 13, 2016 warning letter; a mirrored copy states FDA told Kirkman to discontinue marketing unapproved sodium-fluoride prescription drug products. More than 10 years old, so 25% temporal weight. Calculation: -25 base × 25% = -6.25, rounded to -6. ⁷⁸ January 13, 2016; more than 10 years old as of June 14, 2026, 25% weight. · 25% weight
−6	Repeat inspection history: FDA's 2026 letter states similar CGMP observations were cited in a previous March 19, 2019 inspection. Scored as FDA 483/inspection observations at -12, discounted 50% because the prior inspection is 5-10 years old. Calculation: -12 × 50% = -6. ⁵ March 19, 2019; 5-10 years old, 50% weight. · 50% weight
—	Not scored No FDA closeout letter for the January 2026 warning letter was found. No independent public lab report was found showing contamination or potency failure in current Kirkman dietary supplements.
Value baseline 50 54 Poor
+10	Premium partially justified by testing and specialty hypoallergenic positioning: Kirkman prices are generally above budget brands, but the brand offers allergen-focused formulas, in-house manufacturing, and broad contaminant-testing claims. Awarded +10 of +12 to +18 because premium justification is plausible but weakened by lack of public COAs and the 2026 FDA warning letter. Calculation: +10 × full = +10. ¹²³¹⁸¹⁹²¹ Current 2026 pricing/product evidence; no temporal discount applied. · full weight
+6	Transparent visible unit pricing on sampled product pages: Sampled pages clearly show sale price, count/size, and product form, allowing cost-per-capsule estimates. Awarded +6 of +6 to +10. Calculation: +6 × full = +6. ¹⁸¹⁹²⁰²¹²⁴²⁵ Current 2026 pricing evidence; no temporal discount applied. · full weight
+5	Reasonable specialty-product value in some sampled products: Magnesium bisglycinate 100 mg at $45.50/250 capsules (~$0.18/capsule), zinc picolinate 25 mg at $31/150 (~$0.21/capsule), and calcium 200 mg with D3 at $23.50/120 (~$0.20/capsule) are not budget prices, but they are plausible for hypoallergenic specialty formulas. Awarded modest +5. Calculation: +5 × full = +5. ¹⁸²¹²⁵ Current 2026 pricing evidence; no temporal discount applied. · full weight
−5	Generic single-nutrient price premium versus budget competitors: Kirkman Vitamin D3 4000 IU is $26/120 (~$0.22/capsule), while NOW Vitamin D3 5000 IU is listed by NOW at $10.39/120 (~$0.09/softgel). This is an isolated but clear 100%+ premium in a commodity category, partly mitigated by Kirkman's hypoallergenic capsule and testing claims. Pattern calculation: 1 clear commodity comparison among 6 sampled price checks; apply small penalty above minimum. Calculation: -20 extreme-overprice base × ~25% pattern/mitigation = -5. ¹⁹³⁶ Current/recent 2026 pricing evidence; no temporal discount applied. · full weight
−7	Public verification gap weakens value justification: Premium pricing is harder to justify when batch-level COAs are not public and current NSF/USP certification was not verified. Scored as premium-without-full-verification rather than premium-without-any-justification. Calculation: -7 of -15 to -25 × mitigated = -7. ²³¹¹¹² Current 2026 verification gap; full weight. · full weight
−5	Recent FDA warning letter reduces value-for-quality: Premium pricing depends heavily on trust in manufacturing quality; FDA's 2026 drug CGMP warning letter directly undermines that trust even though it is drug-specific. Calculation: -5 exceptional value-context penalty, kept modest to avoid double-scoring safety/quality too heavily. ⁵ January 27, 2026; within last 2 years, 100% weight. · full weight
—	Not scored Only a limited set of prices and competitors was sampled. Subscription discounts, wholesale/practitioner pricing, shipping costs, and full serving-size details for some multi-ingredient products were not comprehensively audited.
Sentiment baseline 60 80 Strong
+9	BBB A+ rating: BBB lists Kirkman Laboratories with an A+ rating, though not BBB accredited. Awarded +9 of +8 to +12 because rating is strong but accreditation is absent and review volume was not prominent. Calculation: +9 × full = +9. ³⁰ BBB profile crawled in 2026; current reputation signal, full weight. · full weight
+9	Positive product-review pattern on Kirkman's site: Sampled product pages show generally high ratings with meaningful counts, including zinc 4.3/91, Vitamin D3 4.6/64, magnesium bisglycinate 4.7/87, calcium 4.6/88, melatonin 4.4/105, and probiotic 60B product listing. Awarded +9 of +8 to +12 for strong product-level ratings, discounted from high end because reviews are hosted by the seller. Calculation: +9 × full = +9. ¹⁸¹⁹²¹²⁴²⁵ Current product-page evidence observed in 2026; no temporal discount applied. · full weight
+7	Niche practitioner/special-needs recognition: Kirkman is repeatedly framed as serving individuals with special dietary requirements and sensitivities, and user reviews mention doctor/integrative-physician recommendations. Awarded +7 of +8 to +12 because evidence is niche and partly self-hosted, not broad mainstream community consensus. Calculation: +7 × full = +7. ¹¹⁷¹⁸¹⁹³³ Mixed current and recent evidence; full weight for current niche positioning. · full weight
+3	Community mention in celiac/gluten-sensitive context: A 2024 Reddit thread includes a detailed Kirkman response about gluten testing and one follow-up user reporting no reactions after trying a Kirkman product. Awarded +3 as limited but specific positive/neutral community evidence. Calculation: +3 × full = +3. ³¹ 2024-2026 thread activity; within 2 years for original/follow-up, full weight. · full weight
−4	Review-authenticity concern for a sampled Amazon product: ReviewMeta's 2024 analysis of Kirkman Biofilm Defense reported 4.3 rating over 724 ratings but removed 15% potentially unnatural reviews and flagged deleted reviews/suspicious reviewers. This is one product, not a brand-wide finding, so the fake-review penalty is scaled down. Calculation: -15 base × 25% isolated pattern = -4. ³² ReviewMeta report last updated April 24, 2024; within 2-5 years, but still recent enough; rubric weight applied as 75%, rounded into -4 isolated penalty. · 75% weight
−4	Community skepticism around autism-targeted supplement use: Reddit autism/autism-parenting discussions show skepticism toward supplement protocols for autism generally, including Kirkman Spectrum Complete mentioned in a study context. This is not a direct Kirkman product-quality complaint, so scored lightly. Calculation: -4 × full = -4. ³³ 2023 discussion; 2-5 years old, but general sentiment still relevant; 75% already reflected in light penalty. · 75% weight
—	Not scored No large independent Trustpilot dataset was found. Reddit volume is limited. Product reviews were sampled, not exhaustively audited across all Kirkman SKUs and retail channels.

Best for

Sensitive users who need hypoallergenic, gluten/casein-free, low-excipient formulas and are prioritizing allergen profile over lowest price.[^1][^18][^19][^21]
Practitioner-guided users looking for specialty forms such as 5-MTHF, magnesium bisglycinate, zinc picolinate, methylcobalamin, or high-dose vitamin D under monitoring.[^18][^19][^20][^21][^23]
Shoppers who value a brand that discloses testing categories and methods, but who are comfortable with claims-based verification rather than public batch COAs.[^2][^3]

Skip if

You require public, batch-specific COAs or a lot-number lookup before buying; Kirkman describes testing but does not provide a public COA portal in the evidence reviewed.[^2][^3]
You want a brand with a clean recent FDA record; Kirkman/HTO Nevada received a January 2026 FDA drug CGMP warning letter and had a 2026 Class II drug recall.[^5][^9][^10]
You are buying commodity nutrients primarily on price; Kirkman's Vitamin D3 example is much more expensive per unit than NOW's comparable high-potency D3 product.[^19][^36]

Questions

What shoppers ask about Kirkman (Kirkman® / Kirkman Laboratories / Kirkman Group)

Does Kirkman work on the Invincible Show?

This question refers to Robert Kirkman, the comics writer/producer, not Kirkman Laboratories supplements. Robert Kirkman is associated with Invincible as a co-creator and executive-producer-level creative figure for the screen adaptation; that entertainment fact has no relevance to the supplement brand score above.⁴¹⁴²⁴⁴

What comics did Kirkman write?

Robert Kirkman is best known for writing or co-creating comics such as The Walking Dead and Invincible, and he has also worked on titles including Outcast, Marvel Zombies, and other Image/Marvel projects. This is unrelated to Kirkman® supplements and was not used in scoring the supplement brand.⁴²⁴³⁴⁴

Did Robert Kirkman regret killing Glenn?

This is about The Walking Dead, not Kirkman Laboratories. Public discussion around Glenn's death frames it as one of Kirkman's most painful but story-defining choices; it is not evidence for or against the supplement company.⁴³

Who did Mark lose his virginity to in Invincible?

In Invincible comics context, this question refers to Mark Grayson's relationship storyline, not the supplement brand; the commonly cited answer is Amber Bennett. It has no bearing on Kirkman Laboratories' product quality, safety, or transparency.⁴⁴

What comic just sold for $3 million?

This is a comics-collecting question, not a supplement-brand question, and record sales change over time. Recent multi-million-dollar comic sales are typically reported by auction houses and grading companies such as Heritage Auctions/CGC; this fact pattern was not used in the Kirkman supplement score.⁴⁵

Why does Corinthian have teeth for eyes?

The Corinthian is a Sandman/DC character, not related to Kirkman Laboratories. In story terms, the teeth-for-eyes design marks him as a nightmare figure created to unsettle and prey on people, and it has no relevance to the supplement brand assessment.⁴⁶

Sources

1. About Kirkman (2026)
2. Kirkman Ultra Tested® (2026)
3. State-of-the-Art Testing (2026)
4. Kirkman Contact Us (2026)
5. FDA Warning Letter: HTO Nevada, Inc. dba Kirkman - 719074 - 01/27/2026 (2026)
6. FDA Warning Letters and Notice of Violation Letters to Pharmaceutical Companies (2026)
7. FDA Actions to Remove Unapproved Drugs from the Market by Company (2026)
8. FDA Warning Letter to Kirkman Laboratories over fluoride tablets (2016)
9. Multi-event February 2026 FDA Recall Drug by HTO Nevada Inc. dba Kirkman (2026)
10. Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues (2026)
11. NSF Official GMP Listings page (2026)
12. NSF GMP listings page search result / no Kirkman match found in page text (2026)
13. NSF Sourcing Guide historical listing mentioning Kirkman Group, Inc. (2012)
14. SEC filing: Functional Brands / HTO Nevada dba Kirkman ownership and acquisition history (2024)
15. Functional Brands Investor Overview (2026)
16. Kirkman CEO Eric Gripentrog Named CEO of the Year (2023)
17. Kirkman Group LinkedIn profile (2026)
18. Kirkman Zinc Picolinate 25 mg - Hypoallergenic (2026)
19. Kirkman Vitamin D3 4000 IU Caps (2026)
20. Kirkman 5-MTHF ([L/6S]-5-Methyltetrahydrofolate) 5 mg - Hypoallergenic (2026)
21. Kirkman Magnesium Bisglycinate Chelate 100 mg 250 ct (2026)
22. Kirkman Advanced Adult Multivitamin & Mineral with 5-MTHF - Hypoallergenic (2026)
23. Kirkman Super B12 (Methylcobalamin Concentrated Powder) (2026)
24. Kirkman Lacto/Bifido 8-Strain Probiotic (2026)
25. Kirkman Calcium 200 mg with Vitamin D3 - Hypoallergenic (2026)
26. NIH Office of Dietary Supplements: Vitamin D Fact Sheet for Consumers (2026)
27. NIH Office of Dietary Supplements: Magnesium Health Professional Fact Sheet (2026)
28. NIH Office of Dietary Supplements: Zinc Health Professional Fact Sheet (2026)
29. NIH Office of Dietary Supplements: Folate Health Professional Fact Sheet (2026)
30. BBB Business Profile: Kirkman Laboratories (2026)
31. Reddit r/Celiac: Are Kirkman supplements safe? (2024)
32. ReviewMeta: Kirkman Biofilm Defense Amazon Review Analysis (2024)
33. Reddit r/autism discussion mentioning Kirkman Spectrum Complete (2023)
34. Indeed: Working at Kirkman employee reviews (2026)
35. Spokesman-Review: Dietary supplements manufacturing troubles widespread, FDA inspections show (2012)
36. NOW Foods Vitamin D3 5000 IU - 120 Softgels (2026)
37. Seeking Health Optimal Multivitamin (2026)
38. Kirkman TMG 500 mg with Folate & Methyl B12 - Hypoallergenic (2026)
39. Kirkman Enzyme-Aid™ (2026)
40. Kirkman Mushroom Gut Health (2026)
41. Prime Video / Amazon MGM Studios: Invincible series information (2026)
42. Skybound: Robert Kirkman creator profile (2026)
43. The Walking Dead / Image Comics creator interviews and issue context for Glenn's death (2026)
44. Invincible / Skybound comics character context (2026)
45. CGC Comics / Heritage Auctions comic-record-sale coverage (2026)
46. DC Comics: The Sandman / Corinthian character context (2026)

Recalibrated Jun 14, 2026 · 41 scored adjustments · 34 distinct citations across 46 sources